Evidence map›Paper›PMID 32838736›Full record

ArticleBMC nephrology2020

Delayed diagnoses of mitochondrial cytopathies in patients presenting with end stage kidney disease: two case reports.

Tayeba Roper, Mark Harber, Gareth Jones, Robert D S Pitceathly, Alan D Salama

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Tayeba RoperDepartment of Renal Medicine, Guy's & St Thomas' NHS Foundation Trust, Great Maze Pond, London, UK. t.roper@nhs.net.ORCID 0000-0002-4214-4518
Mark HarberUCL Department of Renal Medicine, Royal Free Hospital, Pond Street, Hampstead, London, UK.
Gareth JonesUCL Department of Renal Medicine, Royal Free Hospital, Pond Street, Hampstead, London, UK.
Robert D S PitceathlyDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK.
Alan D SalamaUCL Department of Renal Medicine, Royal Free Hospital, Pond Street, Hampstead, London, UK.
The Royal Free Hospital · GBGuy's and St Thomas' NHS Foundation Trust · GBNational Hospital for Neurology and Neurosurgery · GB

Funding

Department of Health [UK]Medical Research Council MR/S002065/1
6 · The paper itself

Abstract

backgroundUp to one third of patients on renal replacement programmes have an unknown cause of kidney disease, and the diagnosis may only be established following renal transplantation when the disease recurs or if new extra-renal symptoms develop. CASE PRESENTATION: We present two patients who presented with progressive chronic kidney disease of unknown cause. Both patients underwent successful renal transplantation but subsequently developed multisystem abnormalities, and were ultimately diagnosed with mitochondrial cytopathy 10-15 years following transplantation.

conclusionsMitochondrial cytopathies are rare inborn errors of metabolism that should be considered in adults with renal impairment, especially in those with a family history of kidney or other multisystem disease. The widespread availability of genetic testing provides the potential for earlier diagnoses, thereby enhancing management decisions, anticipation of complications, avoidance of mitotoxic drugs, and informed prognosis prediction.

Indexed as

Delayed DiagnosisKidney TransplantationAdultAtrophyBrainBrain DiseasesCognitive DysfunctionDiabetes MellitusFemaleHearing Loss, SensorineuralHumansKidney Failure, ChronicMitochondrial DiseasesMitochondrial Proton-Translocating ATPasesMutationPostoperative ComplicationsMitochondrial Proton-Translocating ATPasesMT-ATP6 protein, humanMT-TL1 tRNA, humanRNA, Transfer, LeuDelayed diagnosesEnd stage renal diseaseInherited conditionsMitochondrial cytopathiesMultisystem disordersPrimary mitochondrial diseaseRenal transplant

Identifiers

PMID32838736
PMCPMC7446060
OpenAlexW3080344360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.